Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial.
Kim HK, Lenze EJ, Ainsworth NJ, Blumberger DM, Brown PJ, Flint AJ, Karp JF, Lavretsky H, Lenard E, Miller JP, Reynolds CF 3rd, Roose SP, Mulsant BH. Kim HK, et al. Among authors: roose sp. J Affect Disord. 2024 Sep 15;361:651-658. doi: 10.1016/j.jad.2024.06.068. Epub 2024 Jun 24. J Affect Disord. 2024. PMID: 38925306 Free article. Clinical Trial.
Retraction notice to "Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study" [J. Affect. Disord. 265 (2020) 439-444].
Rutherford BR, Choi J, Slifstein M, O'Boyle K, Abi-Dargham A, Brown PJ, Wall MW, Vanegas-Arroyave N, Sakhardande J, Stern Y, Roose SP. Rutherford BR, et al. Among authors: roose sp. J Affect Disord. 2023 Jun 1;330:369. doi: 10.1016/j.jad.2023.03.021. Epub 2023 Mar 23. J Affect Disord. 2023. PMID: 36966032 Free PMC article. No abstract available.
Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression.
Vanderschelden B, Gebara MA, Oughli HA, Butters MA, Brown PJ, Farber NB, Flint AJ, Karp JF, Lavretsky H, Mulsant BH, Reynolds CF 3rd, Roose SP, Lenze EJ. Vanderschelden B, et al. Among authors: roose sp. Int J Geriatr Psychiatry. 2023 Jul;38(7):e5964. doi: 10.1002/gps.5964. Int J Geriatr Psychiatry. 2023. PMID: 37392089 Clinical Trial.
Finally, New Hope for the Treatment of LLTRD.
Gebara MA, Brown PJ, Roose SP. Gebara MA, et al. Among authors: roose sp. Am J Geriatr Psychiatry. 2023 Dec;31(12):1042-1044. doi: 10.1016/j.jagp.2023.07.016. Epub 2023 Jul 29. Am J Geriatr Psychiatry. 2023. PMID: 37562991 No abstract available.
Poor Sleep is Common in Treatment-Resistant Late-life Depression and Associated With Poorer Antidepressant Response: Findings From the OPTIMUM Clinical Trial.
Mak MSB, Gebara MA, Lenze EJ, Blumberger DM, Brown PJ, Cristancho P, Flint AJ, Karp JF, Lavretsky H, Miller JP, Reynolds CF 3rd, Roose SP, Mulsant BH, Stahl ST. Mak MSB, et al. Among authors: roose sp. Am J Geriatr Psychiatry. 2025 Jan;33(1):63-72. doi: 10.1016/j.jagp.2024.07.020. Epub 2024 Aug 13. Am J Geriatr Psychiatry. 2025. PMID: 39209616 Free article. Clinical Trial.
Treatment of Cognitive Impairment in Late Life Depression.
Newhouse PA, Roose SP. Newhouse PA, et al. Among authors: roose sp. Am J Geriatr Psychiatry. 2024 Sep 26:S1064-7481(24)00469-X. doi: 10.1016/j.jagp.2024.09.011. Online ahead of print. Am J Geriatr Psychiatry. 2024. PMID: 39389824 No abstract available.
Alcohol and substance use in older adults with treatment-resistant depression.
Srifuengfung M, Lenze EJ, Roose SP, Brown PJ, Lavretsky H, Karp JF, Reynolds CF 3rd, Yingling M, Sa-Nguanpanich N, Mulsant BH. Srifuengfung M, et al. Among authors: roose sp. Int J Geriatr Psychiatry. 2024 Jun;39(6):e6105. doi: 10.1002/gps.6105. Int J Geriatr Psychiatry. 2024. PMID: 38822571 Clinical Trial.
Corrigendum to Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants Randomized. Am J Geriatr Psychiatry 2019;27(10):1138-1152. doi: 10.1016/j.jagp.2019.04.005.
Cristancho P, Lenard E, Lenze EJ, Miller JP, Brown PJ, Roose SP, Montes-Garcia C, Blumberger DM, Mulsant BH, Lavretsky H, Rollman BL, Reynolds CF 3rd, Karp JF. Cristancho P, et al. Among authors: roose sp. Am J Geriatr Psychiatry. 2023 Jun;31(6):472-473. doi: 10.1016/j.jagp.2023.02.042. Epub 2023 Feb 16. Am J Geriatr Psychiatry. 2023. PMID: 36922318 No abstract available.
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.
Lenze EJ, Mulsant BH, Roose SP, Lavretsky H, Reynolds CF 3rd, Blumberger DM, Brown PJ, Cristancho P, Flint AJ, Gebara MA, Gettinger TR, Lenard E, Miller JP, Nicol GE, Oughli HA, Pham VT, Rollman BL, Yang L, Karp JF. Lenze EJ, et al. Among authors: roose sp. N Engl J Med. 2023 Mar 23;388(12):1067-1079. doi: 10.1056/NEJMoa2204462. Epub 2023 Mar 3. N Engl J Med. 2023. PMID: 36867173 Free PMC article. Clinical Trial.
Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition.
Oughli HA, Gebara MA, Ciarleglio A, Lavretsky H, Brown PJ, Flint AJ, Farber NB, Karp JF, Mulsant BH, Reynolds CF 3rd, Roose SP, Yang L, Butters MA, Lenze EJ. Oughli HA, et al. Among authors: roose sp. Am J Geriatr Psychiatry. 2023 Mar;31(3):210-221. doi: 10.1016/j.jagp.2022.11.013. Epub 2022 Dec 5. Am J Geriatr Psychiatry. 2023. PMID: 36529623 Free PMC article. Clinical Trial.
254 results